Brief: Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
16/03/2023 22:39
March 16 (Reuters) - Eton Pharmaceuticals Inc ETON.O :
* ETON PHARMACEUTICALS REPORTS FOURTH QUARTER 2022 FINANCIAL
RESULTS
* ETON PHARMACEUTICALS INC Q4 EARNINGS PER SHARE $0.04
* ETON PHARMACEUTICALS INC Q4 REVENUE $8.5 MILLION
Source text for Eikon: ID:nGNX6MHkWB
Further company coverage: ETON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer